
Chlorthalidone (12.5mg) + Telmisartan (40mg)
Active composition
+1 more active ingredient
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
Nadtel-CH Tablet is a combined antihypertensive medication containing Telmisartan 40mg and Chlorthalidone 12.5mg. Telmisartan, an angiotensin II receptor antagonist, works by blocking the action of angiotensin II, a hormone that narrows blood vessels, thereby reducing blood pressure. Chlorthalidone, a thiazide diuretic, promotes the excretion of salt and water from the body, thereby reducing fluid volume and lowering blood pressure. Nadtel-CH Tablet is indicated for the management of hypertension in adults. It is essential to follow the prescribed dosage regimen and monitor blood pressure regularly. This medication should be used with caution in patients with renal, hepatic, or electrolyte imbalances. Potential side effects include dizziness, headache, and dry mouth. Regular monitoring of blood pressure, serum electrolytes, and kidney function is recommended during treatment.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nadtel-CH Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Nadtel-CH Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Nadtel-CH Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Nadtel-CH Tablet may be needed. Please consult your doctor. Use of Nadtel-CH Tablet is not recommended in these patients.
Exercise Caution
Nadtel-CH Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nadtel-CH Tablet should be used with caution in patients with liver disease. Dose adjustment of Nadtel-CH Tablet may be needed. Please consult your doctor. Use of Nadtel-CH Tablet is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Nadtel-CH Tablet

Telmisartan (40mg) + Chlorthalidone (12.5mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
Nadtel-CH Tablet is a combined antihypertensive medication containing Telmisartan 40mg and Chlorthalidone 12.5mg. Telmisartan, an angiotensin II receptor antagonist, works by blocking the action of angiotensin II, a hormone that narrows blood vessels, thereby reducing blood pressure. Chlorthalidone, a thiazide diuretic, promotes the excretion of salt and water from the body, thereby reducing fluid volume and lowering blood pressure. Nadtel-CH Tablet is indicated for the management of hypertension in adults. It is essential to follow the prescribed dosage regimen and monitor blood pressure regularly. This medication should be used with caution in patients with renal, hepatic, or electrolyte imbalances. Potential side effects include dizziness, headache, and dry mouth. Regular monitoring of blood pressure, serum electrolytes, and kidney function is recommended during treatment.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nadtel-CH Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Nadtel-CH Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Nadtel-CH Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Nadtel-CH Tablet may be needed. Please consult your doctor. Use of Nadtel-CH Tablet is not recommended in these patients.
Exercise Caution
Nadtel-CH Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nadtel-CH Tablet should be used with caution in patients with liver disease. Dose adjustment of Nadtel-CH Tablet may be needed. Please consult your doctor. Use of Nadtel-CH Tablet is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Nadtel-CH Tablet















